CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Single-Arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03710889
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:26.960134+00:00
Published At: 2021-10-15T00:00:00+00:00
Record Updated At: 2021-10-15
Results Posted At: 2021-10-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Osteoporosis, Postmenopausal", "Osteoporosis", "Osteoporosis Vertebral", "Osteoporosis Risk", "Osteoporosis Fracture", "Osteoporosis Localized to Spine", "Osteoporosis, Age-Related", "Osteoporosis Senile", "Osteoporosis of Vertebrae"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-10-15"
protocolSection.identificationModule.nctId: "NCT03710889"
protocolSection.identificationModule.officialTitle: "An Open-Label, Single-Arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-10-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.